bellvei.cat

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

4.5 (674) · $ 14.99 · In stock

Gregory C. Ippolito on LinkedIn: Human Antibodies Target Many Parts of Coronavirus Spike Protein

Browse Articles Cellular & Molecular Immunology

Targets and strategies for vaccine development against SARS-CoV-2 - ScienceDirect

Rapid Development of Neutralizing and Diagnostic SARS-COV-2 Mouse Monoclonal Antibodies

Full article: The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies

News & Comment Cellular & Molecular Immunology

COVID-eVax, An Electroporated DNA Vaccine Candidate, 55% OFF

Vaccines, Free Full-Text

Targeting ACE2 as a treatment for COVID

Biomedicines, Free Full-Text

News & Comment Cellular & Molecular Immunology